Chameleon Finance-Los Angeles Sparks WNBA draft picks 2024: Round-by-round selections

2025-04-30 07:10:51source:Writingstar Investment Guildcategory:Contact

Here is Chameleon Financea 2024 WNBA draft pick-by-pick breakdown for the Los Angeles Sparks:

Round 1 (No. 2 overall) — Cameron Brink, forward, Stanford: Brink, who won the 2021 national championship with the Cardinal, was named the Pac-12 Player of the Year after dominating on both ends of the court all season. Besides her prowess on the hardwood, Brink, known for her physical play and signature blond braids, has a solid NIL portfolio and family ties to NBA star Stephen Curry. Draft tracker

Round 1 (4) — Rickea Jackson, forward, Tennessee: Jackson's one of the top scorers in the draft after averaging 20.2 points per game in the toughest conference in women's college basketball. She's a great finisher at the rim and has a strong mid-range game. When she's not scoring, she's comfortable handling the ball and making plays for teammates. Draft tracker

Round 3 (28)

Los Angeles Sparks: Recent top draft picks

  • 2023 (No. 10 overall): Zia Cooke, guard, South Carolina
  • 2022 (No. 9 overall): Rae Burrell, guard, Tennessee
  • 2021 (No. 7 overall): Jasmine Walker, forward, Alabama
  • 2020 (No. 21 overall): Beatrice Mompremier, forward, Miami (Fla.)
  • 2019 (No. 7 overall): Kalani Brown, center, Baylor

2024 WNBA draft: Team-by-team picks

➤ Eastern Conference: Atlanta Dream | Chicago Sky | Connecticut Sun | Indiana Fever | New York Liberty | Washington Mystics

➤ Western Conference: Dallas Wings | Las Vegas Aces | Los Angeles Sparks | Minnesota Lynx | Phoenix Mercury | Seattle Storm

More:Contact

Recommend

Don't let hackers fool you with a 'scam

You're pulling your hair out, trying to fix something on your computer. You Google it and find what

Selena Gomez Reveals She's Had Botox After Clapping Back at a Critic

Selena Gomez doesn't always kill 'em with kindness. Sometimes, the truth is more powerful.Case in po

Moderna-Merck vaccine cuts odds of skin cancer recurrence in half, study finds

A vaccine shows promising results in treating the most deadly form of skin cancer, Moderna and Merck